SCHEMBL22915170

SCHEMBL22915170

C/C=C/N=C/c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.50
▸ GRIN2D O15399 2/20 0.42
▸ GRIN3B O60391 2/20 0.42
▸ GRIN1 Q05586 2/20 0.42
▸ GRIN2A Q12879 2/20 0.42
▸ GRIN2B Q13224 2/20 0.42
▸ GRIN2C Q14957 2/20 0.42
▸ GRIN3A Q8TCU5 2/20 0.42
▸ AMY1A P0DUB6 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ TRPA1 O75762 1/20 0.37
▸ G6PC1 P35575 1/20 0.37
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22915185 0.78 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL11065985 0.77 LMNA (0.50) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11065989 0.77 LMNA (0.50) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1613354 0.72 MAOB (0.58) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL25918878 0.72 MAOB (0.58) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11260669 0.72 MAOB (0.58) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL24000964 0.71 MAPT (0.50) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11776185 0.71 GRIN2D (0.64) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11776182 0.71 GRIN2D (0.64) MAOBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL432740 0.69 AHR (0.54) MAOBMAPTHSD17B10HTTAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3770146-A1 PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF Mitobridge, Inc. (US) 2021-01-27 — — EP disclosed
Send feedback